PSEN1 and Alzheimer disease: As a consequence, mutations in PSEN1, impairing the activity of γ-secretase complex, may lead to the production of more aggregation-prone forms of the Aβ peptide, that is a typical hallmark of AD, thus inducing the disease development (Figure 3) [3,4].